| | Publication Year | Title | Author(s) |
| 81 | May-2017 | Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: an early decision analytic model of multiplex targeted sequencing. | Doble, Brett; John, Thomas ; Thomas, David; Fellowes, Andrew; Fox, Stephen; Lorgelly, Paula |
| 82 | 22-Apr-2017 | PD-L1 and tumor infiltrating lymphocytes as prognostic markers in resected NSCLC | Ameratunga, Malaka; Asadi, Khashayar ; Lin, Xihui; Walkiewicz, Marzena; Murone, Carmel ; Knight, Simon; Mitchell, Paul L R ; Boutros, Paul; John, Thomas |
| 83 | Apr-2017 | Is Mesothelioma in China Rare or Misdiagnosed? | John, Thomas ; Russell, Prudence A; Thapa, Bibhusal |
| 84 | 15-Feb-2017 | Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma. | Wu, Licun; Allo, Ghassan; John, Thomas ; Li, Ming; Tagawa, Tetsuzo; Opitz, Isabelle; Anraku, Masaki; Yun, Zhihong; Pintilie, Melania; Pitcher, Bethany; Liu, Geoffrey; Feld, Ron; Johnston, Michael R; de Perrot, Marc; Tsao, Ming-Sound |
| 85 | 2017 | The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma. | Thapa, Bibhusal ; Salcedo, Adriana; Lin, Xihui; Walkiewicz, Marzena; Murone, Carmel ; Ameratunga, Malaka; Asadi, Khashayar ; Deb, Siddhartha; Barnett, Stephen A ; Knight, Simon; Mitchell, Paul L R ; Watkins, D Neil; Boutros, Paul C; John, Thomas |
| 86 | Dec-2016 | Lung cancer in 2016: immunotherapy comes of age | Mitchell, Paul L R ; John, Thomas |
| 7 | Dec-2016 | Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma. | Thapa, Bibhusal ; Walkiewicz, Marzena; Murone, Carmel ; Asadi, Khashayar ; Deb, Siddhartha; Barnett, Stephen A ; Knight, Simon R ; Mitchell, Paul L R ; Liew, Danny; Watkins, D Neil; John, Thomas |
| 8 | 18-Oct-2016 | Digital PCR of genomic rearrangements for monitoring circulating tumour DNA | Do, Hongdo; Cameron, Daniel; Molania, Ramyar; Thapa, Bibhusal ; Rivall, Gareth; Mitchell, Paul L R ; Murone, Carmel ; John, Thomas ; Papenfuss, Anthony; Dobrovic, Alexander |
| 9 | 12-Oct-2016 | Targeting the vasculature: anti-angiogenic agents for malignant mesothelioma | Chia, Puey Ling ; Russell, Prudence A; Scott, Andrew M ; John, Thomas |
| 10 | 6-Oct-2016 | Immunotherapy for malignant mesothelioma: reality check | Thapa, Bibhusal ; Watkins, D Neil; John, Thomas |
| 11 | 1-Sep-2016 | The ADAM trial: visiting the road less traveled | Arulananda, Surein; John, Thomas |
| 12 | Aug-2016 | Temporal changes of EGFR mutations and T790M levels in tumour and plasma DNA following AZD9291 treatment | Chia, Puey Ling ; Do, Hongdo; Morey, Adrienne; Mitchell, Paul L R ; Dobrovic, Alexander ; John, Thomas |
| 13 | Jun-2016 | Severe Psoriasis Flare After Anti-Programmed Death Ligand 1 (PD-L1) Therapy for Metastatic Non-Small Cell Lung Cancer (NSCLC). | Chia, Puey Ling ; John, Thomas |
| 14 | 31-May-2016 | Current and evolving methods to visualize biological data in cancer research | Chia, Puey Ling ; Gedye, Craig; Boutros, Paul C; Wheatley-Price, Paul; John, Thomas |
| 15 | Dec-2015 | Vortex Keratopathy Presumed Secondary to AZD9291. | Chia, Puey Ling ; John, Thomas |
| 16 | 1-Apr-2015 | Role of immunotherapy in lung cancer: Preliminary results of new vaccines and immune checkpoint inhibitors. | John, Thomas |
| 17 | 20-Nov-2014 | Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors. | Chia, Puey Ling ; Mitchell, Paul L R ; Dobrovic, Alexander ; John, Thomas |
| 18 | 30-Apr-2014 | Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine. | Wright, Gavin M; Do, Hongdo; Weiss, Jonathan; Alam, Naveed Z; Rathi, Vivek; Walkiewicz, Marzena; John, Thomas ; Russell, Prudence A; Dobrovic, Alexander |
| 19 | 26-Feb-2014 | A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma. | Do, Hongdo; Wong, Nicholas C; Murone, Carmel ; John, Thomas ; Solomon, Benjamin J; Mitchell, Paul L R ; Dobrovic, Alexander |
| 20 | 4-Nov-2013 | Should we screen for lung cancer in Australia? | Mitchell, Paul L R ; John, Thomas |